Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)

China flag China · Delayed Price · Currency is CNY
23.41
+0.36 (1.56%)
Jul 16, 2025, 2:45 PM CST
222.90%
Market Cap6.77B
Revenue (ttm)813.32M
Net Income (ttm)28.72M
Shares Out289.15M
EPS (ttm)0.10
PE Ratio238.98
Forward PEn/a
Dividend0.10 (0.43%)
Ex-Dividend DateJul 9, 2025
Volume26,773,631
Average Volume57,269,573
Open26.04
Previous Close23.05
Day's Range23.11 - 26.04
52-Week Range6.66 - 32.14
Beta0.66
RSI42.52
Earnings DateAug 28, 2025

About SHE:002365

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China. [Read more]

Sector Healthcare
Founded 2001
Employees 930
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002365
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.